Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Acute Lung Injury Market From 2025 To 2029?

The market size for acute lung injury has consistently expanded over the past few years. Predictions suggest an increase from $2.48 billion in 2024 to $2.59 billion in 2025, implying a compound annual growth rate (CAGR) of 4.5%. Factors contributing to this growth during the historical period include awareness drives, a rise in the number of ICU admissions, the impact of smoking and air pollution, infections contracted in hospitals, and initiatives to lower the mortality rate.

In the coming years, we can expect the acute lung injury market to undergo robust growth, expanding to an estimated size of $3.07 billion in 2029 with a compound annual growth rate (CAGR) of 4.3%. This growth trajectory during the forecast period is largely due to factors including advancements in biologics and gene-based treatments, generous government funding, the emergence of precision medicine as well as stem cell and regenerative therapies, and sweeping global health policy changes. Prominent trends projected for the forecasted period encompass the advancement of biologic drugs, increased use of wearable and remote monitoring devices, the rise of inhalation therapies, burgeoning CRISPR and gene editing technologies, and usage of biosensors for instantaneous analysis.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20704&type=smp

What Are the Core Growth Drivers Propelling the Acute Lung Injury Market Forward?

The acute lung injury market growth is poised to be propelled by the escalating instances of respiratory diseases. A whole range of conditions that impact the lungs and additional parts of the respiratory system, such as causing breathlessness and impacting lung functionality, constitute respiratory diseases. Several factors contribute to the surge in respiratory disease prevalence, including enhanced air pollution, smoking, inactive lifestyles, progressively aging populations, and the effects of viral infections. Severe inflammation and Damage to the alveoli, causing issues with gas exchange and respiratory distress, can result from respiratory diseases like pneumonia and thereby cause acute lung injury. The Australian Bureau of Statistics reported in September 2023 that the mortality rate due to influenza and pneumonia in their country escalated from 31.9 per 100,000 people in 2021 to 42.6 per 100,000 individuals in 2022, showing a significant rise of about 33.54%. Hence, the escalating prevalence of respiratory diseases is fuelling the advance of the acute lung injury market.

What Segment Types Define the Acute Lung Injury Market Structure?

The acute lung injurymarket covered in this report is segmented –

1) By Injury Type: Direct Injury; Indirect Injury

2) By Therapy: Mechanical Ventilation; Pharmacotherapy; Fluid Management; Other Therapies

3) By End User: Hospitals; Clinics; Other End Users

Subsegments:

1) By Direct Injury: Trauma-Induced Acute Lung Injury; Aspiration Pneumonitis; Pneumonia-Related Acute Lung Injury; Inhalation Injury

2) By Indirect Injury: Sepsis-Related Acute Lung Injury; Shock-Induced Acute Lung Injury; Acute Lung Injury Due To Blood Transfusion; Acute Lung Injury Associated With Pancreatitis

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20704&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Acute Lung Injury Market?

North America was the largest region in the acute lung injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute lung injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing theAcute Lung Injury Industry Evolution?

Key players in the acute lung injury market are concentrating on the creation of innovative treatments, such as peptide therapies, to maintain their market position. Peptide therapies involve using short sequences of amino acids, or peptides, as medicinal agents for treating various health issues. For example, in November 2022, Zuventus Healthcare Ltd., an Indian healthcare company, rolled out a new treatment called Aviptadil for patients suffering from acute respiratory distress syndrome (ARDS). This treatment possesses several distinctive advantages, including a highly effective vasodilatory function that is 50 times more potent than prostacyclin, a protective mechanism for the lungs that encourages surfactant production through the activation of alveolar type II cells, anti-inflammatory attributes that restrain pro-inflammatory cytokines like IL-6 and TNF-alpha, and an immunomodulatory function to control immune reactions within the lungs. Notably, Aviptadil has demonstrated its clinical effectiveness in enhancing the prognosis for patients with severe viral-induced ARDS.

View the full report here:

https://www.thebusinessresearchcompany.com/report/acute-lung-injury-global-market-report

What Is the Definition of the Acute Lung Injury Market?

Acute lung injury (ALI) is a severe condition characterized by widespread inflammation and damage to the lungs, leading to impaired oxygen exchange. It is often triggered by direct factors such as pneumonia or trauma, or indirect causes such as sepsis or pancreatitis. ALI results in symptoms such as shortness of breath, low oxygen levels, and respiratory distress.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20704

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model